ScinoPharm Taiwan Ltd. | Mutual Funds
Mutual Funds that own ScinoPharm Taiwan Ltd.
Vanguard Emerging Markets Stock Index Fund
3,986,576
0.5%
0
0.01%
07/31/2018
Government Pension Fund - Global (The)
3,927,849
0.5%
554,546
0%
12/31/2017
Vanguard Total International Stock Index Fund
3,688,060
0.47%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
2,359,027
0.3%
0
0.01%
09/05/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
776,182
0.1%
0
0.01%
09/05/2018
Vanguard FTSE All World (ex-US) Small Cap
639,891
0.08%
0
0.01%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
631,075
0.08%
-275,000
0%
04/30/2018
SPDR S&P Emerging Markets Small Cap ETF
499,500
0.06%
0
0.11%
09/06/2018
DFA Emerging Markets Small Cap Series
478,000
0.06%
-72,000
0.01%
01/31/2018
Capital Large Cap Growth Fund
301,633
0.04%
301,633
1.48%
03/31/2018
| Address |
No. 1 Nan-Ke 8th Road
Tainan TQ 741 44
Taiwan
|
|
Employees
|
- |
| Website |
http://www.scinopharm.com.tw |
| Updated |
07/08/2019 |
| ScinoPharm Taiwan Ltd. engages in the manufacture and sale of pharmaceutical raw materials. It offers drug development technology, chemical process development, analytical chemistry, and manufacturing services. The company was founded November 11, 1997 and is headquartered in Tainan, Taiwan. |
